Solving humanity’s healthcare crisis means turning to AI

AI’s Breakthrough: Akido Labs’ Scope AI Redefines Global Healthcare Access and Equity

Prashant Samant, Co-founder and CEO of Akido Labs, highlighted a severe global healthcare crisis. Six in ten Americans (211 million) suffer from chronic illness, and 74% of global deaths are from preventable chronic conditions. The existing infrastructure fails billions due to a critical worldwide shortage of medical professionals. The US needs four times its 550,000 doctors, while Liberia’s 900 doctors cover only 4% of its 5.4 million people. A global shortfall of 11 million healthcare workers by 2030 cannot be solved by human training alone.

Akido Labs proposes artificial intelligence as a transformative solution. AI can dramatically increase medical visit supply, limited only by compute power. Unlike general AI, specialized medical AI demands deep, extensive knowledge. Akido Labs spent six years building the “world’s largest medical textbook,” compiling over 10 million clinical case studies, far exceeding human training.

To address complex “edge cases,” Akido Labs established its own healthcare system. Here, 240 human doctors treat patients, and real-time clinical data continuously feeds into the AI, simulating a vast, continuous residency program. This rigorous development created Scope AI, the world’s first omni-specialty medical mind.

Scope AI engages patients, asks questions, performs differential diagnoses, and formulates comprehensive care plans, providing transparent explanations. In a demonstration, Mr. Samant played a patient, while Jared Goodner, Co-founder and CTO, acted as a non-clinical concierge guided by Scope AI. Scope AI dynamically extracts clinical details, running them against millions of case studies to form an evidence-weighted diagnosis, mirroring a human doctor’s process.

After narrowing diagnoses, Scope AI recommends tests, generates a progress note, and suggests lifestyle changes and prescriptions. Crucially, a human Akido physician reviews and modifies this draft care plan in real-time, ensuring all orders are submitted with essential human oversight. Scope AI is implemented in Akido Labs’ Southern California clinics, offering in-person patient visits with extended 45-minute consultations and next-day appointments.

Doctors experience reduced administrative burden and a fourfold increase in daily patient capacity. R&D concluded in 2023, with the first AI-run patient visit in 2024 for cardiology, quickly expanding to numerous specialties. By the end of 2025, over 250,000 patients will access Scope AI-led visits. Mr. Samant envisions arming 16 million International Red Cross aid workers with Scope, potentially providing 11 visits per person annually for the global population, transforming healthcare from scarcity to abundance and achieving health equity.